ArticleJournal of clinical medicine2022
Clinical Implementational and Site-Specific Workflows for a 1.5T MR-Linac.
Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 17 citations in OpenAlex.
- ACPSEM guideline: commissioning and quality assurance of Magnetic Resonance Imaging Linear Accelerators.Physical and engineering sciences in medicine · 2026Article
- Commissioning of a motion management system for a 1.5T Elekta Unity MR-Linac: A single institution experience.Journal of applied clinical medical physics · 2025Article
- Patient setup variation on Elekta Unity and its impact on adaptive planning.Journal of applied clinical medical physics · 2025Article
- Case report: Clinical workflow considerations for treating soft-tissue sarcoma on a 1.5-T MR-Linac.Technical innovations & patient support in radiation oncology · 2025Article
- Surrogate gating strategies for the Elekta Unity MR-Linac gating system.Journal of applied clinical medical physics · 2025Article
- Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility.Clinical and translational radiation oncology · 2024Article
- Characterization of spatial integrity with active and passive implants in a low-field magnetic resonance linear accelerator scanner.Physics and imaging in radiation oncology · 2024Article
- A new workflow of the on-line 1.5-T MR-guided adaptive radiation therapy.Japanese journal of radiology · 2023Article
- A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT).Clinical and translational radiation oncology · 2023Article
- Intra-fraction motion of pelvic oligometastases and feasibility of PTV margin reduction using MRI guided adaptive radiotherapy.Frontiers in oncology · 2023Article
- Simulating an intra-fraction adaptive workflow to enable PTV margin reduction in MRIgART volumetric modulated arc therapy for prostate SBRT.Frontiers in oncology · 2023Article
- MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.Acta clinica Croatica · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MR-guided adaptive radiotherapy (MRgART) provides opportunities to benefit patients through enhanced use of advanced imaging during treatment for many patients with various cancer treatment sites. This novel technology presents many new challenges which vary based on anatomic treatment location, technique, and potential changes of both tumor and normal tissue during treatment. When introducing new treatment sites, considerations regarding appropriate patient selection, treatment planning, immobilization, and plan-adaption criteria must be thoroughly explored to ensure adequate treatments are performed. This paper presents an institution's experience in developing a MRgART program for a 1.5T MR-linac for the first 234 patients. The paper suggests practical treatment workflows and considerations for treating with MRgART at different anatomical sites, including imaging guidelines, patient immobilization, adaptive workflows, and utilization of bolus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.